Life Stance Health Group, Inc. LFST
We take great care to ensure that the data presented and summarized in this overview for LifeStance Health Group, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding LFST
View all-
Tpg Gp A, LLC Fort Worth, TX161MShares$749 Million50.15% of portfolio
-
Summit Partners L P41.9MShares$195 Million67.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$57 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$38.8 Million0.0% of portfolio
-
Jennison Associates LLC7.27MShares$33.9 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.57MShares$30.6 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.53MShares$25.7 Million0.0% of portfolio
-
Brown Advisory Inc5.21MShares$24.3 Million0.04% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.07MShares$23.6 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.57MShares$21.3 Million0.0% of portfolio
Latest Institutional Activity in LFST
Top Purchases
Top Sells
About LFST
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Insider Transactions at LFST
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 11
2025
|
Kenneth A Burdick |
BUY
Open market or private purchase
|
Direct |
20,000
+0.29%
|
$80,000
$4.45 P/Share
|
|
Aug 08
2025
|
Kenneth A Burdick |
BUY
Open market or private purchase
|
Indirect |
46,511
+50.0%
|
$186,044
$4.3 P/Share
|
|
Aug 08
2025
|
Kenneth A Burdick |
BUY
Open market or private purchase
|
Direct |
47,670
+0.69%
|
$190,680
$4.34 P/Share
|
|
Jun 16
2025
|
Ujjwal Ramtekkar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,519
-8.39%
|
$47,595
$5.17 P/Share
|
|
Jun 11
2025
|
Teresa De Luca |
BUY
Grant, award, or other acquisition
|
Direct |
35,714
+24.97%
|
-
|
|
Jun 11
2025
|
Robert Bessler |
BUY
Grant, award, or other acquisition
|
Direct |
35,714
+38.27%
|
-
|
|
Jun 11
2025
|
Eric Shuey |
BUY
Grant, award, or other acquisition
|
Direct |
35,714
+27.54%
|
-
|
|
Jun 11
2025
|
Vukasin Paunovich Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
178,571
+50.0%
|
-
|
|
Jun 11
2025
|
Eric P Palmer |
BUY
Grant, award, or other acquisition
|
Direct |
71,428
+50.0%
|
-
|
|
Jun 05
2025
|
Ujjwal Ramtekkar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,000
-12.36%
|
$80,000
$5.94 P/Share
|
|
Apr 09
2025
|
Robert Bessler |
SELL
Open market or private sale
|
Indirect |
4,900
-0.17%
|
$34,300
$7.01 P/Share
|
|
Apr 08
2025
|
Robert Bessler |
SELL
Open market or private sale
|
Indirect |
14
-0.0%
|
$98
$7.0 P/Share
|
|
Apr 01
2025
|
Ryan Pardo |
SELL
Payment of exercise price or tax liability
|
Direct |
9,377
-1.0%
|
$56,262
$6.63 P/Share
|
|
Mar 24
2025
|
Ryan Mc Groarty |
BUY
Grant, award, or other acquisition
|
Direct |
184,911
+25.24%
|
-
|
|
Mar 17
2025
|
Lisa K Miller |
SELL
Open market or private sale
|
Direct |
18,845
-5.25%
|
$113,070
$6.9 P/Share
|
|
Mar 10
2025
|
Lisa K Miller |
SELL
Payment of exercise price or tax liability
|
Direct |
10,655
-3.14%
|
$74,585
$7.11 P/Share
|
|
Mar 10
2025
|
David Bourdon Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,884
-1.21%
|
$76,188
$7.11 P/Share
|
|
Mar 10
2025
|
Kenneth A Burdick |
SELL
Payment of exercise price or tax liability
|
Direct |
35,817
-1.05%
|
$250,719
$7.11 P/Share
|
|
Mar 10
2025
|
Ryan Pardo |
SELL
Payment of exercise price or tax liability
|
Direct |
12,280
-1.32%
|
$85,960
$7.11 P/Share
|
|
Mar 10
2025
|
Ujjwal Ramtekkar Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,346
-3.25%
|
$30,422
$7.11 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.7M shares |
|---|---|
| Open market or private purchase | 114K shares |
| Payment of exercise price or tax liability | 688K shares |
|---|---|
| Open market or private sale | 176K shares |